Annual ROA
-96.01%
-48.79%-103.32%
December 31, 2023
Summary
- As of February 12, 2025, TCRT annual return on assets is -96.01%, with the most recent change of -48.79% (-103.32%) on December 31, 2023.
- During the last 3 years, TCRT annual ROA has fallen by -33.40% (-53.35%).
- TCRT annual ROA is now -291.08% below its all-time high of -24.55%, reached on December 31, 2009.
Performance
TCRT ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-209.18%
-65.01%-45.09%
September 30, 2024
Summary
- As of February 12, 2025, TCRT quarterly return on assets is -209.18%, with the most recent change of -65.01% (-45.09%) on September 30, 2024.
- Over the past year, TCRT quarterly ROA has dropped by -65.01% (-45.09%).
- TCRT quarterly ROA is now -629.61% below its all-time high of -28.67%, reached on June 30, 2010.
Performance
TCRT Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
TCRT ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -103.3% | -45.1% |
| 3 y3 years | -53.4% | -208.3% |
| 5 y5 years | -81.4% | -343.3% |
TCRT ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -103.3% | at low | -350.7% | at low |
| 5 y | 5-year | -103.3% | +16.8% | -350.7% | at low |
| alltime | all time | -291.1% | +99.8% | -629.6% | +99.9% |
Alaunos Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -209.18%(+45.1%) |
| Jun 2024 | - | -144.17%(+18.8%) |
| Mar 2024 | - | -121.36%(+16.9%) |
| Dec 2023 | -96.01%(+103.3%) | -103.84%(+30.0%) |
| Sep 2023 | - | -79.85%(+22.6%) |
| Jun 2023 | - | -65.12%(+16.5%) |
| Mar 2023 | - | -55.89%(+14.4%) |
| Dec 2022 | -47.22%(-27.7%) | -48.86%(+5.3%) |
| Sep 2022 | - | -46.41%(-18.8%) |
| Jun 2022 | - | -57.18%(-9.7%) |
| Mar 2022 | - | -63.33%(-5.1%) |
| Dec 2021 | -65.30%(+4.3%) | -66.71%(-1.7%) |
| Sep 2021 | - | -67.85%(+13.3%) |
| Jun 2021 | - | -59.87%(+18.1%) |
| Mar 2021 | - | -50.71%(+1.6%) |
| Dec 2020 | -62.61%(-45.7%) | -49.90%(+5.7%) |
| Sep 2020 | - | -47.19%(-49.3%) |
| Jun 2020 | - | -93.08%(-11.7%) |
| Mar 2020 | - | -105.37%(-14.3%) |
| Dec 2019 | -115.39%(+118.0%) | -123.01%(-6.2%) |
| Sep 2019 | - | -131.20%(+95.1%) |
| Jun 2019 | - | -67.26%(+8.9%) |
| Mar 2019 | - | -61.74%(+0.3%) |
| Dec 2018 | -52.94%(+3.3%) | -61.58%(+3.4%) |
| Sep 2018 | - | -59.53%(+13.0%) |
| Jun 2018 | - | -52.67%(+2.0%) |
| Mar 2018 | - | -51.66%(+4.6%) |
| Dec 2017 | -51.26%(-59.7%) | -49.40%(+6.1%) |
| Sep 2017 | - | -46.56%(+5.8%) |
| Jun 2017 | - | -44.02%(-69.3%) |
| Mar 2017 | - | -143.59%(+12.4%) |
| Dec 2016 | -127.12%(+5.3%) | -127.76%(+11.5%) |
| Sep 2016 | - | -114.55%(-3.3%) |
| Jun 2016 | - | -118.52%(+218.8%) |
| Mar 2016 | - | -37.18%(-61.1%) |
| Dec 2015 | -120.72%(+122.2%) | -95.61%(-17.3%) |
| Sep 2015 | - | -115.60%(-14.0%) |
| Jun 2015 | - | -134.36%(-7.7%) |
| Mar 2015 | - | -145.50%(+160.8%) |
| Dec 2014 | -54.33%(-26.2%) | -55.80%(-0.9%) |
| Sep 2014 | - | -56.29%(-26.9%) |
| Jun 2014 | - | -77.03%(-22.0%) |
| Mar 2014 | - | -98.75%(+1.5%) |
| Dec 2013 | -73.61%(-26.7%) | -97.26%(-18.8%) |
| Sep 2013 | - | -119.75%(+26.6%) |
| Jun 2013 | - | -94.61%(+15.5%) |
| Mar 2013 | - | -81.90%(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -100.39%(+33.5%) | -85.77%(+29.9%) |
| Sep 2012 | - | -66.04%(+33.2%) |
| Jun 2012 | - | -49.59%(+27.9%) |
| Mar 2012 | - | -38.78%(-32.4%) |
| Dec 2011 | -75.20%(+28.0%) | -57.40%(-5.2%) |
| Sep 2011 | - | -60.58%(-23.3%) |
| Jun 2011 | - | -78.98%(+11.1%) |
| Mar 2011 | - | -71.06%(+30.1%) |
| Dec 2010 | -58.73%(+139.2%) | -54.63%(+35.2%) |
| Sep 2010 | - | -40.42%(+41.0%) |
| Jun 2010 | - | -28.67%(-69.5%) |
| Mar 2010 | - | -93.87%(+105.5%) |
| Dec 2009 | -24.55%(-76.0%) | -45.68%(-64.8%) |
| Sep 2009 | - | -129.70%(+6.7%) |
| Jun 2009 | - | -121.61%(+8.2%) |
| Mar 2009 | - | -112.41%(+4.8%) |
| Dec 2008 | -102.36%(+27.4%) | -107.30%(+11.8%) |
| Sep 2008 | - | -95.96%(+14.3%) |
| Jun 2008 | - | -83.97%(+17.5%) |
| Mar 2008 | - | -71.46%(+13.7%) |
| Dec 2007 | -80.34%(-12.3%) | -62.83%(+6.9%) |
| Sep 2007 | - | -58.79%(+15.7%) |
| Jun 2007 | - | -50.80%(-15.8%) |
| Mar 2007 | - | -60.34%(-20.0%) |
| Dec 2006 | -91.56%(-47.4%) | -75.42%(+4.2%) |
| Sep 2006 | - | -72.36%(-32.0%) |
| Jun 2006 | - | -106.42%(-44.9%) |
| Mar 2006 | - | -193.18%(-9.7%) |
| Dec 2005 | -174.03%(-77.9%) | -213.86%(-43.7%) |
| Sep 2005 | - | -379.63%(-86.7%) |
| Jun 2005 | - | -2858.88%(+32.5%) |
| Mar 2005 | - | -2157.74%(+56.3%) |
| Dec 2004 | -787.15%(-98.7%) | -1380.46%(-99.1%) |
| Sep 2004 | - | -159.16 K%(+839.5%) |
| Jun 2004 | - | -16.94 K%(+226.0%) |
| Mar 2004 | - | -5197.10%(-28.8%) |
| Dec 2003 | -59.98 K%(+2442.2%) | -7300.81%(+375.2%) |
| Sep 2003 | - | -1536.34%(+19.9%) |
| Jun 2003 | - | -1281.55%(+20.6%) |
| Mar 2003 | - | -1062.93%(-37.2%) |
| Dec 2002 | -2359.18%(-5.6%) | -1692.99%(-23.4%) |
| Sep 2002 | - | -2210.74%(+59.3%) |
| Jun 2002 | - | -1387.93%(+19.9%) |
| Mar 2002 | - | -1157.91%(-6.7%) |
| Dec 2001 | -2500.00% | -1241.33%(+182.3%) |
| Sep 2001 | - | -439.73%(-17.4%) |
| Jun 2001 | - | -532.35% |
FAQ
- What is Alaunos Therapeutics annual return on assets?
- What is the all time high annual ROA for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual ROA year-on-year change?
- What is Alaunos Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly ROA year-on-year change?
What is Alaunos Therapeutics annual return on assets?
The current annual ROA of TCRT is -96.01%
What is the all time high annual ROA for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual return on assets is -24.55%
What is Alaunos Therapeutics annual ROA year-on-year change?
Over the past year, TCRT annual return on assets has changed by -48.79% (-103.32%)
What is Alaunos Therapeutics quarterly return on assets?
The current quarterly ROA of TCRT is -209.18%
What is the all time high quarterly ROA for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly return on assets is -28.67%
What is Alaunos Therapeutics quarterly ROA year-on-year change?
Over the past year, TCRT quarterly return on assets has changed by -65.01% (-45.09%)